118 related articles for article (PubMed ID: 35501644)
21. Non-coding RNA LOXL1-AS1 exhibits oncogenic activity in ovarian cancer via regulation of miR-18b-5p/VMA21 axis.
Xue F; Xu YH; Shen CC; Qin ZL; Zhou HB
Biomed Pharmacother; 2020 May; 125():109568. PubMed ID: 32058209
[TBL] [Abstract][Full Text] [Related]
22. Long noncoding RNA SNHG14 promotes hepatocellular carcinoma progression by regulating miR-876-5p/SSR2 axis.
Liao Z; Zhang H; Su C; Liu F; Liu Y; Song J; Zhu H; Fan Y; Zhang X; Dong W; Chen X; Liang H; Zhang B
J Exp Clin Cancer Res; 2021 Jan; 40(1):36. PubMed ID: 33485374
[TBL] [Abstract][Full Text] [Related]
23. Long non-coding RNA OIP5-AS1 suppresses microRNA-92a to augment proliferation and metastasis of ovarian cancer cells through upregulating ITGA6.
Wang Y; Li L; Zhang X; Zhao X
J Ovarian Res; 2022 Feb; 15(1):25. PubMed ID: 35168644
[TBL] [Abstract][Full Text] [Related]
24. Long non-coding RNA SNHG1 stimulates ovarian cancer progression by modulating expression of miR-454 and ZEB1.
Wu Y; Zhu B; Yan Y; Bai S; Kang H; Zhang J; Ma W; Gao Y; Hui B; Li R; Zhang X; Ren J
Mol Oncol; 2021 May; 15(5):1584-1596. PubMed ID: 33641229
[TBL] [Abstract][Full Text] [Related]
25. Upregulation of lncRNA AB073614 functions as a predictor of epithelial ovarian cancer prognosis and promotes tumor growth in vitro and in vivo.
Zeng S; Liu S; Feng J; Gao J; Xue F
Cancer Biomark; 2019; 24(4):421-428. PubMed ID: 30909184
[TBL] [Abstract][Full Text] [Related]
26. Long noncoding RNA SNHG14 enhances migration and invasion of ovarian cancer by upregulating DGCR8.
Zhao JL; Wang CL; Liu YL; Zhang GY
Eur Rev Med Pharmacol Sci; 2019 Dec; 23(23):10226-10233. PubMed ID: 31841176
[TBL] [Abstract][Full Text] [Related]
27. Long non-coding RNA SNHG14 promotes microglia activation by regulating miR-145-5p/PLA2G4A in cerebral infarction.
Qi X; Shao M; Sun H; Shen Y; Meng D; Huo W
Neuroscience; 2017 Apr; 348():98-106. PubMed ID: 28215748
[TBL] [Abstract][Full Text] [Related]
28. lncRNA CCAT1 promotes cell proliferation, migration, and invasion by down-regulation of miR-143 in FTC-133 thyroid carcinoma cell line.
Yang T; Zhai H; Yan R; Zhou Z; Gao L; Wang L
Braz J Med Biol Res; 2018; 51(6):e7046. PubMed ID: 29791590
[TBL] [Abstract][Full Text] [Related]
29. Long non-coding RNA CCAT1 promotes cervical cancer cell proliferation and invasion by regulating the miR-181a-5p/MMP14 axis.
Shen H; Wang L; Xiong J; Ren C; Gao C; Ding W; Zhu D; Ma D; Wang H
Cell Cycle; 2019 May; 18(10):1110-1121. PubMed ID: 31084453
[TBL] [Abstract][Full Text] [Related]
30. Role of extracellular LncRNA-SNHG14/miRNA-3940-5p/NAP12 mRNA in colorectal cancer.
Matboli M; Shafei AE; Ali MA; El-Din Ahmed TS; Naser M; Abdel-Rahman T; Anber N; Ali M
Arch Physiol Biochem; 2021 Dec; 127(6):479-485. PubMed ID: 31397210
[TBL] [Abstract][Full Text] [Related]
31. LncRNA CCAT1 promotes prostate cancer cells proliferation, migration, and invasion through regulation of miR-490-3p/FRAT1 axis.
Cai X; Dai Y; Gao P; Ren G; Cheng D; Wang B; Wang Y; Yu J; Du Y; Wang X; Xue B
Aging (Albany NY); 2021 Jul; 13(14):18527-18544. PubMed ID: 34319909
[TBL] [Abstract][Full Text] [Related]
32. Silencing of lncRNA DLEU1 inhibits tumorigenesis of ovarian cancer via regulating miR-429/TFAP2A axis.
Xu H; Wang L; Jiang X
Mol Cell Biochem; 2021 Feb; 476(2):1051-1061. PubMed ID: 33170430
[TBL] [Abstract][Full Text] [Related]
33. CCAT1 promotes triple-negative breast cancer progression by suppressing miR-218/ZFX signaling.
Han C; Li X; Fan Q; Liu G; Yin J
Aging (Albany NY); 2019 Jul; 11(14):4858-4875. PubMed ID: 31310241
[TBL] [Abstract][Full Text] [Related]
34. Long non-coding RNA CCAT1 sponges miR-490 to enhance cell proliferation and migration of non-small cell lung cancer.
Wang J; Sun N; Han W; Tong L; Xu T; Li G
Thorac Cancer; 2021 Feb; 12(3):364-371. PubMed ID: 33325119
[TBL] [Abstract][Full Text] [Related]
35. LncRNA TONSL-AS1 regulates miR-490-3p/CDK1 to affect ovarian epithelial carcinoma cell proliferation.
Liu Y; Li L; Wang X; Wang P; Wang Z
J Ovarian Res; 2020 May; 13(1):60. PubMed ID: 32414422
[TBL] [Abstract][Full Text] [Related]
36. LncRNA SNHG14 regulates the DDP-resistance of non-small cell lung cancer cell through miR-133a/HOXB13 pathway.
Xu L; Xu Y; Yang M; Li J; Xu F; Chen BL
BMC Pulm Med; 2020 Oct; 20(1):266. PubMed ID: 33059643
[TBL] [Abstract][Full Text] [Related]
37. LncRNA HOXD-AS1 promotes epithelial ovarian cancer cells proliferation and invasion by targeting miR-133a-3p and activating Wnt/β-catenin signaling pathway.
Zhang Y; Dun Y; Zhou S; Huang XH
Biomed Pharmacother; 2017 Dec; 96():1216-1221. PubMed ID: 29239819
[TBL] [Abstract][Full Text] [Related]
38. SNHG14 promotes the tumorigenesis and metastasis of colorectal cancer through miR-32-5p/SKIL axis.
Ye T; Zhang N; Wu W; Yang B; Wang J; Huang W; Tang D
In Vitro Cell Dev Biol Anim; 2019 Dec; 55(10):812-820. PubMed ID: 31471872
[TBL] [Abstract][Full Text] [Related]
39. lncRNA-SNHG14 Plays a Role in Acute Lung Injury Induced by Lipopolysaccharide through Regulating Autophagy via miR-223-3p/Foxo3a.
Hong J; Mo S; Gong F; Lin Z; Cai H; Shao Z; Yang X; Sun R; Zhang Q; Liu J
Mediators Inflamm; 2021; 2021():7890288. PubMed ID: 34539244
[TBL] [Abstract][Full Text] [Related]
40. Long non-coding RNA SNHG14 aggravates LPS-induced acute kidney injury through regulating miR-495-3p/HIPK1.
Yang N; Wang H; Zhang L; Lv J; Niu Z; Liu J; Zhang Z
Acta Biochim Biophys Sin (Shanghai); 2021 May; 53(6):719-728. PubMed ID: 33856026
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
